Interview, Fireside Chat
Amazon's PillPack Acquisition: Unraveling the $1 Billion Deal with Co-Founder TJ Parker
- Plans to offer B2B infrastructure to startups for pharmacy launches were established using existing technology, insurance contracts, and licensing.
- A potential sale of the company was initially targeted for the back half of 2017 pending specific terms, which were assumed to be met.
- An early 2018 deal obstruction reduced expected financial runway from six months to approximately two months.
- Acquisition efforts involved travel to San Francisco, New York, and Seattle to meet with potential buyers by the end of the week.
- Alignment of visions regarding the shoppable pharmacy experience confirmed the intent to sell the company to Amazon prior to the Seattle meeting.
- Regulatory processes are identified as a source of stress during the period from announcement to close for entrepreneurs.
- A prediction is made that a significant number of deals may fail to close due to government oversight rather than due diligence issues.
- The launch of Amazon Pharmacy is described as successfully operational and humming along.
- The expectation is that additional initiatives will emerge as byproducts of the thinking and systems built for Amazon Clinic.
- There is a firm economic expectation that no regret exists regarding the decision to sell rather than continue operations independently.